Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.730
-0.009 (-1.20%)
At close: Dec 5, 2025, 4:00 PM EST
0.713
-0.017 (-2.38%)
After-hours: Dec 5, 2025, 7:05 PM EST
Cytosorbents Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 46 | 50 | 58 | 68 | 182 | 344 | |
| Market Cap Growth | -9.91% | -14.14% | -14.31% | -62.87% | -47.06% | 175.66% | |
| Enterprise Value | 65 | 71 | 68 | 58 | 135 | 272 | |
| Last Close Price | 0.73 | 0.91 | 1.11 | 1.55 | 4.19 | 7.97 | |
| PS Ratio | 1.19 | 1.40 | 1.86 | 1.95 | 4.22 | 8.39 | |
| PB Ratio | 5.08 | 4.48 | 2.47 | 1.91 | 2.91 | 4.34 | |
| P/TBV Ratio | 8.45 | 6.76 | 2.96 | 2.18 | 3.15 | 4.59 | |
| EV/Sales Ratio | 1.77 | 1.99 | 2.18 | 1.69 | 3.12 | 6.64 | |
| Debt / Equity Ratio | 3.01 | 2.42 | 0.78 | 0.52 | 0.22 | 0.01 | |
| Asset Turnover | 0.79 | 0.71 | 0.54 | 0.45 | 0.48 | 0.70 | |
| Inventory Turnover | 2.98 | 3.43 | 2.67 | 3.39 | 2.97 | 4.62 | |
| Quick Ratio | 1.48 | 1.08 | 1.44 | 2.86 | 4.14 | 7.54 | |
| Current Ratio | 2.11 | 2.20 | 1.81 | 3.48 | 4.70 | 8.12 | |
| Return on Equity (ROE) | -93.26% | -119.80% | -99.38% | -67.00% | -34.64% | -18.97% | |
| Return on Assets (ROA) | -19.01% | -20.91% | -34.37% | -25.27% | -15.84% | -11.05% | |
| Return on Capital (ROIC) | -23.42% | -26.30% | -41.85% | -29.69% | -18.15% | -12.99% | |
| Return on Capital Employed (ROCE) | -39.90% | -44.70% | -82.10% | -57.70% | -30.00% | -13.00% | |
| Earnings Yield | -22.39% | -41.64% | -50.47% | -48.51% | -13.48% | -2.28% | |
| FCF Yield | -21.85% | -29.57% | -38.29% | -50.74% | -9.69% | -1.84% | |
| Buyback Yield / Dilution | -14.92% | -21.90% | -2.49% | -0.49% | -11.70% | -20.35% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.